Endo International Equity 2024

Endo International Aktienanalyse

What does Endo International do?

Endo International PLC is a global pharmaceutical company based in Ireland, specializing in the development, manufacturing, and distribution of prescription medications. The company was founded in New York City in 1920 as a small narcotic business and has since undergone significant changes and expansion through mergers and acquisitions. Endo now has its headquarters in Dublin, Ireland and a diverse portfolio of prescription drugs in various therapeutic areas. The company's business model focuses on the development and marketing of innovative and generic pharmaceuticals, medical devices, and diagnostic solutions to improve global patient health. It operates in five segments: Branded Pharmaceuticals, Generics, International Pharmaceuticals, Urology, and Specialty Products. The Branded Pharmaceuticals segment includes a wide range of prescription drugs targeting various indications, including pain relievers, hormone therapies, gastrointestinal products, and oncology treatments. Some of Endo's well-known brands include Lidoderm, Voltaren, and Percocet. The Generics division produces and distributes a variety of generic medications under different brand names, utilizing synergies within its network to reduce manufacturing costs and pass savings on to customers. The International Pharmaceuticals unit is responsible for Endo's global business, maintaining partnerships and joint ventures with partners worldwide and expanding the company's portfolio into new regions and markets. The Urology segment offers a broad spectrum of products and services for urology, including surgical and non-surgical procedures. This includes the globally top-selling transurethral resection generator, the GreenLight Laser. Endo's Specialty Products segment manufactures devices and active ingredients for critical infrastructure used in medical research and development. This unit has heavily focused on developing innovative solutions for medical challenges in recent years. Overall, Endo holds approximately 1% market share of the global pharmaceutical market. To strengthen its competitive position, the company focuses on expanding its product portfolio, increasing efficiency, and reducing costs. Endo has a strong presence in the American and European markets and is also active in emerging economies. It follows a growth strategy that emphasizes the introduction of new and innovative products to further expand its existing segments and explore new business areas. In 2020, Endo employed over 3500 employees worldwide and generated approximately $2.5 billion in revenue. The company aims to solidify its position as a leading pharmaceutical company and expand its influence in the global market. Endo International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Endo International's Equity

Endo International's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Endo International's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Endo International's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Endo International's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Endo International’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Endo International stock

What is the equity of Endo International this year?

Endo International has equity of -6.6 B USD this year.

What was the equity of Endo International compared to the previous year?

The equity of Endo International has increased/decreased by 58.51% increased compared to the previous year.

What impact does a high equity have on investors of Endo International?

A high equity is advantageous for investors of Endo International as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Endo International?

A low equity can be a risk for investors of Endo International, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Endo International affect the company?

An increase in equity of Endo International can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Endo International affect the company?

A reduction in equity of Endo International can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Endo International?

Some factors that can affect the equity of Endo International include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Endo International so important for investors?

The equity of Endo International is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Endo International take to change the equity?

To change equity, Endo International can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Endo International pay?

Over the past 12 months, Endo International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Endo International is expected to pay a dividend of 0 USD.

What is the dividend yield of Endo International?

The current dividend yield of Endo International is .

When does Endo International pay dividends?

Endo International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Endo International?

Endo International paid dividends every year for the past 0 years.

What is the dividend of Endo International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Endo International located?

Endo International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Endo International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Endo International from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Endo International pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Endo International in the year 2023?

In the year 2023, Endo International distributed 0 USD as dividends.

In which currency does Endo International pay out the dividend?

The dividends of Endo International are distributed in USD.